← FDA Drug Approvals (Drugs@FDA)

RAMELTEON

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2015-08-19

Drug application

FDA Application #
ANDA091610
Application type
Abbreviated New Drug Application (Generic)
Brand name
RAMELTEON
Generic name
RAMELTEON
Active ingredients
RAMELTEON
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
ACTAVIS LABS FL INC
Manufacturer
Actavis Pharma, Inc.
First approval
2015-08-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown